Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor β
Article first published online: 7 APR 2005
Copyright © 2005 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 52, Issue 4, pages 1248–1258, April 2005
How to Cite
Bhattacharyya, S., Ghosh, A. K., Pannu, J., Mori, Y., Takagawa, S., Chen, G., Trojanowska, M., Gilliam, A. C. and Varga, J. (2005), Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor β. Arthritis & Rheumatism, 52: 1248–1258. doi: 10.1002/art.20996
- Issue published online: 7 APR 2005
- Article first published online: 7 APR 2005
- Manuscript Accepted: 29 DEC 2004
- Manuscript Received: 29 JUN 2004
- Scleroderma Foundation
- NIH. Grant Number: AR-46390
- NIH. Grant Number: AR-049284
- NIH. Grant Numbers: AR-42309, AR-49025
Transforming growth factor β (TGFβ) induces profibrotic responses in normal fibroblasts, and plays a fundamental role in the pathogenesis of fibrosis in scleroderma (systemic sclerosis [SSc]). The intensity of cellular responses elicited by cytokines is modulated by transcriptional coactivators such as the histone acetylase p300. The objective of these studies was to delineate the physiologic role of p300 in Smad-dependent profibrotic responses elicited by TGFβ.
Ectopic p300 was transiently expressed in normal dermal fibroblasts. Cellular p300 levels were suppressed using p300-specific ribozymes. The regulation of gene expression was examined by transient transfection assays, Northern blotting, and immunoblot analysis. The expression of p300 in normal and scleroderma fibroblasts was evaluated by confocal microscopy and immunoblotting, and p300 levels in skin from mice with experimental scleroderma were assessed by immunohistochemistry.
In normal fibroblasts, TGFβ induced an increase in the levels of p300. Forced expression of ectopic p300 in these cells dramatically enhanced the magnitude of TGFβ responses, whereas selective depletion of p300 using ribozyme resulted in abrogation of TGFβ-induced collagen synthesis and promoter activity. Furthermore, TGFβ lost its ability to induce Smad-dependent transcription in p300-depleted fibroblasts. These responses could be fully rescued with ectopic p300. Abrogation of Smad-mediated TGFβ signaling was not due to alterations in the levels or the ligand-dependent phosphorylation or intracellular trafficking of endogenous Smads. Immunohistochemical analysis demonstrated substantially increased p300 expression in lesional skin from mice with chronic graft-versus-host disease, an animal model of scleroderma. Furthermore, levels of p300 were 2–3–fold higher in cultured fibroblasts derived from SSc patients than in fibroblasts from matched normal controls.
These results establish, for the first time, that the coactivator histone acetylase p300, itself a target of TGFβ regulation, is an essential component of the cellular TGFβ signal transduction pathways mediating stimulation of collagen synthesis in fibroblasts. Since the cellular abundance of p300 appears to govern the intensity of profibrotic responses elicited by TGFβ, elevated p300 expression in lesional tissue may contribute to the progression of skin fibrosis in scleroderma.